Delivery Order SPE2DB25D3202-SPE2DB25FTBDP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,054.35 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of April 22, 2025. This competitive, non-set-aside award reflects the agency's procurement of critical pharmaceutical supplies for military and federal healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a key vendor for...
- The Defense Logistics Agency awarded a $1,562.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of June 3, 2025. This non-set-aside contract represents a routine pharmaceutical procurement to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,124.64 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of August 15, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded on August 14, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $1,827.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a completion date of September 15, 2025. This non-set-aside contract was competitively awarded on September 12, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $26,739.67 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The contract, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award status. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,374.24 for NovoLog 100 Unit/mL FlexPen 3mL insulin pens on August 22, 2025, with completion scheduled for August 25, 2025. This firm fixed-price contract represents a non-competitive, direct award to the vendor for pharmaceutical supply fulfillment. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for...
- The Defense Logistics Agency awarded a delivery order valued at $1,125.13 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of August 15, 2025. This competitive award, issued on August 14, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, valued at $1,150.32. This is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $4,055.27 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3 mL insulin pens, with an ultimate completion date of July 30, 2025. This non-set-aside, firm fixed-price delivery order represents a competitively awarded pharmaceutical supply transaction supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,751.48 for NovoLog 100 Unit/mL FlexPen 3mL insulin pens on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to supply pharmaceutical products supporting federal military and veteran healthcare systems. The work will be performed at AmerisourceBergen's corporate office in...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTBDPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,171.75 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply pharmaceutical products and medical commodities—including specialty medications, brand-name and generic drugs, vaccines, and related supplies—to support military healthcare programs globally. The pharmaceutical supply supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with DLA planning future multi-award Pharmaceutical Prime Vendor Global Program Generation V contracts by region.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/14/25 |